Pfizer Pauses Experimental Gene Therapy Trial After Boy’s ‘Sudden’ Death

Pharmaceutical giant Pfizer Inc. has halted a study of an experimental gene therapy for muscular dystrophy after a child who received the treatment died due to cardiac arrest.

The New York City-headquartered drugmaker revealed the boy’s sudden death in a community letter shared by the nonprofit advocacy group Parent Project Muscular Dystrophy (PPMD).

The child—who was not identified by the company—received the investigational recombinant adeno-associated virus gene therapy known as fordadistrogene movaparvovec as part of Pfizer’s phase 2 “DAYLIGHT” study for Duchenne muscular dystrophy (DMD) in early 2023, the company said.

According to Pfizer, the “DAYLIGHT” study enrolled children between the ages of two and four.

The study has since concluded, Pfizer said.

Read Full Article Here
 

Follow us

Read our latest news on any of these social networks!

Get latest news delivered daily!

We will send you breaking news right to your inbox


Have a tip? Let us know!

Recent Articles

  • by:
  • Source: AP News
  • 03/14/2025
...
Trump administration asks Supreme Court to partly allow birthright citizenship restrictions

The Trump administration is asking the Supreme Court to allow restrictions on birthright citizenship to partly take effect while legal fights play out.

  • by:
  • Source: Fox News
  • 03/14/2025
...
Chuck Schumer will vote to keep government open: 'For Donald Trump, a shutdown would be a gift'

Senate Minority Leader Chuck Schumer, D-N.Y., says he will vote to keep the government open, warning that a shutdown has worse consequences for Americans and would only empower President Donald Trump and Elon Musk further.

...
More than 2,000 laid off at Johns Hopkins University amid Trump budget cuts

Johns Hopkins University announced Thursday it's laying off over 2,000 employees amid budget cuts made by the Trump administration.

...
ICE: US Immigration Detention Maxed at 47.6K Detainees

U.S. immigration detention is filled to capacity at 47,600 detainees, a senior U.S. Immigration and Customs Enforcement official said on a call with reporters on Wednesday, adding that the Trump administration was seeking more bed space.